Dr. Martens (DOCS) Competitors

Vistry Group (LON:VTY) and Dr. Martens (LON:DOCS) are both small-cap consumer cyclical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, community ranking, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

Which has more risk & volatility, VTY or DOCS?

Vistry Group has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Comparatively, Dr. Martens has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500.

Is VTY or DOCS a better dividend stock?

Vistry Group pays an annual dividend of GBX 55 per share and has a dividend yield of 9.0%. Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 4.5%. Vistry Group pays out 73.1% of its earnings in the form of a dividend. Dr. Martens pays out 42.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Is VTY or DOCS more profitable?

Dr. Martens has a net margin of 7.89% compared to Vistry Group's net margin of 6.90%. Dr. Martens' return on equity of 18.91% beat Vistry Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vistry Group	6.90%	7.69%	3.43%
Dr. Martens	7.89%	18.91%	8.12%

Does the MarketBeat Community favor VTY or DOCS?

Vistry Group received 39 more outperform votes than Dr. Martens when rated by MarketBeat users. However, 91.67% of users gave Dr. Martens an outperform vote while only 56.18% of users gave Vistry Group an outperform vote.

Company	Underperform	Outperform
Vistry Group	Outperform Votes 50 56.18%	Underperform Votes 39 43.82%
Dr. Martens	Outperform Votes 11 91.67%	Underperform Votes 1 8.33%

Do analysts rate VTY or DOCS?

Vistry Group currently has a consensus target price of GBX 670, suggesting a potential upside of 10.11%. Given Vistry Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe Vistry Group is more favorable than Dr. Martens.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vistry Group	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Dr. Martens	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has stronger valuation and earnings, VTY or DOCS?

Vistry Group has higher revenue and earnings than Dr. Martens. Vistry Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vistry Group	£3.55B	0.56	£245.05M	£75.26	8.08
Dr. Martens	£874.20M	0.74	£68.97M	£7.05	9.38

Does the media favor VTY or DOCS?

In the previous week, Dr. Martens had 1 more articles in the media than Vistry Group. MarketBeat recorded 1 mentions for Dr. Martens and 0 mentions for Vistry Group. Vistry Group's average media sentiment score of 0.00 equaled Dr. Martens'average media sentiment score.

Company	Overall Sentiment
Vistry Group	Neutral
Dr. Martens	Neutral

Do insiders & institutionals have more ownership in VTY or DOCS?

76.0% of Vistry Group shares are held by institutional investors. Comparatively, 69.5% of Dr. Martens shares are held by institutional investors. 0.6% of Vistry Group shares are held by insiders. Comparatively, 4.4% of Dr. Martens shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Vistry Group and Dr. Martens tied by winning 9 of the 18 factors compared between the two stocks.